gadolinium dtpa has been researched along with bilirubin in 26 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (bilirubin) | Trials (bilirubin) | Recent Studies (post-2010) (bilirubin) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 25,921 | 1,337 | 5,871 |
| Protein | Taxonomy | gadolinium dtpa (IC50) | bilirubin (IC50) |
|---|---|---|---|
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3884 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.3183 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (42.31) | 24.3611 |
| 2020's | 10 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Blumenfield, DM; Blumetti, RF; Goldstein, HA; Holyoak, WL; Hugo, FP; Kashanian, FK | 1 |
| Niendorf, HP; Seifert, W | 1 |
| Christensen, T; Lundorf, E; Svaland, MG | 1 |
| Hatakeyama, S; Ikeda, H; Kuroiwa, M; Matsuyama, S; Murakami, J; Sakurai, M; Suzuki, N; Takahashi, A; Tsuchida, Y | 1 |
| Anelli, PL; Cupelli, F; Lorusso, V; Pascolo, L; Tiribelli, C; Uggeri, F; Visigalli, M | 1 |
| Hyodo, T; Ishii, K; Kitano, M; Kudo, M; Kumano, S; Murakami, T; Numata, K; Okada, M | 1 |
| Ba-Ssalamah, A; Gruenberger, T; Nolz, R; Prusa, AM; Schindl, M; Wibmer, A | 1 |
| Fuchsjäger, M; Kalmar, P; Lutfi, A; Quehenberger, F; Reiter, U; Schöllnast, H; Steiner, J; Talakic, E | 1 |
| Ezziddin, S; Fimmers, R; Hadizadeh, DR; Kukuk, GM; Schaefer, SG; Schild, HH; Spengler, U; Willinek, WA | 1 |
| Hernando, D; Reeder, SB; Vigen, KK; Wells, SA | 1 |
| Cai, H; Chan, T; Dong, Z; Feng, ST; Li, ZP; Luo, Y; Wu, L; Zheng, K | 1 |
| Chang, WC; Chen, RC; Chou, CT; Lin, CY | 1 |
| Kobayashi, S; Miyati, T; Shiozaki, T; Takatsu, Y | 1 |
| Chernyak, V; Flusberg, M; Kobi, M; Paroder, V; Rozenblit, AM | 1 |
| Breitenstein, S; Froehlich, JM; Gutzeit, A; Koh, DM; Kolokythas, O; Matoori, S; Pozdniakova, V; Reischauer, C | 1 |
| Bernasconi, DP; Famularo, S; Gandola, D; Giani, A; Gianotti, L; Ippolito, D; Orsini, EB; Pecorelli, A; Pinotti, E; Romano, F; Sironi, S | 1 |
| Kobayashi, S; Miyati, T; Nakamura, M; Takatsu, Y | 1 |
| Chayama, K; Johnson, PJ; Kumada, T; Ogawa, S; Tada, T; Takeshima, K; Tanaka, J; Toyoda, H; Yasuda, S | 1 |
| Baba, M; Furuya, K; Iwaya, A; Machimura, H; Mori, H | 1 |
| Choi, SY; Hwang, JA; Kim, SH; Lee, JE; Min, JH; Moon, JY | 1 |
| Sookaromdee, P; Wiwanitkit, V | 1 |
| Ando, H; Atsukawa, M; Ikejima, K; Nagahara, A; Nakadera, E; Okubo, H; Okubo, T | 1 |
| Aslan, S; Cakir, IM; Eryuruk, U; Tasdemir, MN | 1 |
| Buckstein, M; Khan, F; Kyriakakos, CK; Moshier, E; Nehlsen, AD; Sindhu, KK; Taouli, B; Ward, SC; Wolken, T | 1 |
| Gotohda, N; Kobayashi, S; Kobayashi, T; Konishi, M; Kudo, M; Sugimoto, M | 1 |
| Baek, J; Chang, Y; Cho, SH; Je, H; Park, SY; Ryeom, H; Yeo, B | 1 |
5 trial(s) available for gadolinium dtpa and bilirubin
| Article | Year |
|---|---|
Safety assessment of gadopentetate dimeglumine in U.S. clinical trials.
Topics: Bilirubin; Clinical Trials as Topic; Contrast Media; Drug Combinations; Electrocardiography; Electroencephalography; Gadolinium; Gadolinium DTPA; Headache; Humans; Iron; Magnetic Resonance Imaging; Meglumine; Nausea; Organometallic Compounds; Paresthesia; Pentetic Acid; Research Design; Sorbitol; United States | 1990 |
Serum iron and serum bilirubin after administration of Gd-DTPA-dimeglumine. A pharmacologic study in healthy volunteers.
Topics: Adult; Bilirubin; Contrast Media; Drug Combinations; Gadolinium DTPA; Humans; Iron; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Random Allocation; Sorbitol | 1988 |
Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study.
Topics: Adult; Aged; Bilirubin; Blood Pressure; Central Nervous System Diseases; Contrast Media; Double-Blind Method; Female; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Pentetic Acid; Safety; Spinal Cord Diseases | 1994 |
MRI findings in the liver in biliary atresia patients after the Kasai operation.
Topics: Alanine Transaminase; Biliary Atresia; Bilirubin; Child; Child, Preschool; Cholinesterases; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; gamma-Glutamyltransferase; Humans; Liver; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Portoenterostomy, Hepatic | 1997 |
Impact of the introduction of direct-acting anti-viral drugs on hepatocarcinogenesis: a prospective serial follow-up MRI study.
Topics: Aged; alpha-Fetoproteins; Antiviral Agents; Bilirubin; Carcinoma, Hepatocellular; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Hepatitis C; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Serum Albumin; Sex Characteristics; Sustained Virologic Response | 2020 |
21 other study(ies) available for gadolinium dtpa and bilirubin
| Article | Year |
|---|---|
Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents.
Topics: Animals; Anion Transport Proteins; Bilirubin; Binding, Competitive; Biological Transport; Carrier Proteins; Cell Membrane; Contrast Media; Gadolinium DTPA; Humans; Kinetics; Liver; Magnetic Resonance Imaging; Meglumine; Oocytes; Organometallic Compounds; Osmolar Concentration; Rats; RNA, Messenger; Sulfobromophthalein; Taurocholic Acid; Xenopus laevis | 1999 |
Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Bile Ducts; Bilirubin; Biomarkers; Contrast Media; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Infusions, Intravenous; Japan; Liver; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Predictive Value of Tests | 2012 |
Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers; Contrast Media; Female; Gadolinium DTPA; Hepatectomy; Humans; Liver Failure; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Postoperative Complications; Preoperative Care; Prothrombin Time; Retrospective Studies; Risk Assessment | 2013 |
Gd-EOB-DTPA enhanced MRI of the liver: correlation of relative hepatic enhancement, relative renal enhancement, and liver to kidneys enhancement ratio with serum hepatic enzyme levels and eGFR.
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers; Cholinesterases; Contrast Media; Female; Gadolinium DTPA; Glomerular Filtration Rate; Humans; Image Enhancement; Kidney; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2014 |
Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests.
Topics: Adult; Aged; Aged, 80 and over; Alanine Transaminase; Bilirubin; Biomarkers; Contrast Media; Female; Gadolinium DTPA; gamma-Glutamyltransferase; Glutamate Dehydrogenase; Humans; L-Lactate Dehydrogenase; Liver Diseases; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Serum Albumin | 2014 |
Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(⁎).
Topics: Adult; Aged; Aged, 80 and over; Bilirubin; Contrast Media; End Stage Liver Disease; Female; Gadolinium; Gadolinium DTPA; Hepatocytes; Humans; Image Processing, Computer-Assisted; Linear Models; Liver; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Water; Young Adult | 2015 |
Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity.
Topics: Adult; Aged; Bile Duct Neoplasms; Bilirubin; Cholangiocarcinoma; Female; Gadolinium DTPA; Humans; Jaundice; Magnetic Resonance Imaging; Male; Middle Aged; Tumor Burden; Young Adult | 2015 |
Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
Topics: Adult; Bilirubin; Contrast Media; Gadolinium DTPA; Humans; Image Enhancement; Kidney; Liver; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Retrospective Studies | 2015 |
Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin-bilirubin grading system.
Topics: Aged; Aged, 80 and over; Bile Ducts; Bilirubin; Contrast Media; Female; Gadolinium DTPA; Hepatitis B; Hepatitis C; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Serum Albumin; Spleen | 2016 |
Limitations of GD-EOB-DTPA-enhanced MRI: can clinical parameters predict suboptimal hepatobiliary phase?
Topics: Bilirubin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Prognosis; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Serum albumin, total bilirubin, and patient age are independent confounders of hepatobiliary-phase gadoxetate parenchymal liver enhancement.
Topics: Adult; Aged; Bilirubin; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; gamma-Glutamyltransferase; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Serum Albumin | 2019 |
Estimating liver function in a large cirrhotic cohort: Signal intensity of gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI.
Topics: Aged; Bilirubin; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Italy; Liver; Liver Cirrhosis; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies | 2019 |
Prediction of Sufficient Liver Enhancement on the Gadoxetate Disodium-enhanced Hepatobiliary Phase Imaging Using Transitional Phase Images and Albumin-bilirubin Grade.
Topics: Adult; Aged; Albumins; Bilirubin; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Spleen | 2021 |
Comparison of liver scintigraphy and the liver-spleen contrast in Gd-EOB-DTPA-enhanced MRI on liver function tests.
Topics: Aged; Aged, 80 and over; Albumins; Bilirubin; Contrast Media; Female; Gadolinium DTPA; Humans; Image Processing, Computer-Assisted; Liver; Liver Function Tests; Magnetic Resonance Imaging; Male; Middle Aged; Radionuclide Imaging; Reproducibility of Results; Spleen; Tomography, X-Ray Computed | 2021 |
Total Bilirubin Level as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bilirubin; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Sensitivity and Specificity | 2022 |
Total Bilirubin Levels as a Predictor of Suboptimal Image Quality of the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI in Patients with Extrahepatic Bile Duct Cancer: Correspondence.
Topics: Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Bilirubin; Gadolinium DTPA; Humans; Magnetic Resonance Imaging | 2022 |
Gadoxetic acid-enhanced magnetic resonance imaging predicts hyperbilirubinemia induced by glecaprevir during hepatitis C virus treatment.
Topics: Aminoisobutyric Acids; Bilirubin; Cyclopropanes; Gadolinium DTPA; Hepacivirus; Hepatitis C; Humans; Hyperbilirubinemia; Lactams, Macrocyclic; Leucine; Magnetic Resonance Imaging; Proline; Quinoxalines; Sulfonamides | 2022 |
Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS.
Topics: Albumins; Bilirubin; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Reproducibility of Results; Retrospective Studies | 2022 |
Characterization and Prediction of Signal Intensity Changes in Normal Liver Parenchyma on Gadoxetic Acid-enhanced MRI Scans after Liver-directed Radiation Therapy.
Topics: Aged; Bilirubin; Carcinoma, Hepatocellular; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Radiation Injuries; Retrospective Studies | 2022 |
Liver functional assessment using time-associated change in the liver-to-spleen signal intensity ratio on enhanced magnetic resonance imaging: a retrospective study.
Topics: Bilirubin; Contrast Media; Gadolinium DTPA; Hepatectomy; Humans; Indocyanine Green; Liver; Liver Failure; Liver Function Tests; Liver Neoplasms; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Retrospective Studies; Spleen | 2023 |
Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors.
Topics: Bilirubin; Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Retrospective Studies; Sensitivity and Specificity | 2023 |